Antheia
Menlo Park, US · Founded 2013 · Delaware corporation · 3 known investors
Antheia manufactures biosynthetic active pharmaceutical ingredients and key starting materials for essential medicines using advanced fermentation-based biosynthesis, replacing traditional agricultural sourcing to improve pharmaceutical supply chain reliability. The company serves pharmaceutical manufacturers and drug developers seeking more efficient, sustainable, and consistent sources for complex medicine ingredients.
Founders & leadership
RS
Ram ShriramDirector
CT
Catherine ThodeyDirector
CD
Christina D. SmolkeExecutive Officer, Director
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$9.2MraisedSep 2018 · 5 investors · Other TechnologyRule 506(b)
▶$9.2MraisedSep 2018 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ram ShriramDirector
- Valerie MinassianExecutive Officer
- Catherine ThodeyDirector
- Christina D. SmolkeExecutive Officer, Director
- Offering amount
- $15.5M
- Amount sold
- $9.2M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedMay 2017 · 4 investors · Other TechnologyRule 506(b)
▶$6.2MraisedMay 2017 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Catherine ThodeyDirector
- Christina D. SmolkeExecutive Officer, Director
- Ram ShriramDirector
- Offering amount
- $25M
- Amount sold
- $6.2M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2MraisedMar 2015 · 10 investors · Other TechnologyRule 506(b)
▶$2MraisedMar 2015 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ram ShriramDirector
- Catherine ThodeyDirector
- Christina D. SmolkeExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Antheia seals 2nd series C funding close, hitting more than $175M in a yearfiercepharma.com · 2026
- Antheia Raises $24M in Second Close of Series C Financingfinsmes.com · 2026
- Antheia Raises Additional $24 Million to Complete Series C Financing, Bringing Total Funds Raised to More than $175 Million Over Past Yearprnewswire.com · 2026
- Antheia Raises $56M in Series C Fundingfinsmes.com · 2025
- Medpathtrial.medpath.com · 2025
- Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy - Antheiaantheia.bio · 2025